12/21
Headlines

Analysis

After Market Losers: Horizon Technology Finance (NASDAQ:HRZN), Caesars Entertainment (NASDAQ:CZR), Walter Energy (NYSE:WLT), Vipshop Holdings Ltd. (NYSE:VIPS)

Chris Lewis02 mins

Horizon Technology Finance (NASDAQ:HRZN) is lower in late trading after the company reported mixed financial results for Q4. Shares are down 0.57% at $14.02, with a 52-week range of $12.77 – $15.51. The closed-end, non-diversified management investment company reported Q4 net investment income of $0.35 per share, compared with the prior-year period’s $0.36 per share….

Read More

Intraday Financial Gainers: Comcast (NASDAQ:CMCSA), J.C. Penney (NYSE:JCP), IsoRay, Inc. (NYSEMKT:ISR), Boyd Gaming (NYSE:BYD)

Colin Pettis04 mins

Comcast (NASDAQ:CMCSA) shares firm Tuesday as the company is contemplating a deal with Japanese electronics maker Sharp. Sharp would build liquid crystal display (LCD) televisions with a built-in cable channel receiver, Kyodo reported. The Japanese news agency said Sharp is trying to pursuing growth by focusing on its sluggish LCD TV operations. Comcast did not…

Read More

Boyd Gaming (NYSE:BYD) Surges After Hours; Hill International (NYSE:HIL), Atlas Financial Holdings Inc. (NASDAQ:AFH), Summit Midstream Partners, LP (NYSE:SMLP), American Eagle Energy (NYSEMKT:AMZG)

Mark DeFrance05 mins

Boyd Gaming (NYSE:BYD) is surging in after-hours trading after activist hedge fund Elliott Associates disclosed a stake in the casino operator. In a filing with the SEC, Elliott disclosed it owns 4.99% of Boyd’s outstanding common stock, with a 2.05% exposure to common shares via derivatives. Elliott said its combined economic exposure to Boyd (NYSE:BYD)…

Read More

Pharma in Focus After Hours: Kythera (NASDAQ:KYTH), La Jolla Pharmaceutical (NASDAQ:LJPC), Medifast (NYSE:MED)

Mark Doerr03 mins

Kythera (NASDAQ:KYTH) and Bayer ADR (OTCMRKTS:BAYRY) announced that Kythera acquired all rights outside of the U.S. and Canada to ATX-101, a proprietary formulation of a purified synthetic version of deoxycholic acid currently in late-stage development for the reduction of submental fat (double chin). In 2010, KYTHERA (NASDAQ:KYTH) licensed the commercial rights to ATX-101 outside of…

Read More